okt 8 Search Results


okt8 anti cd8  (ATCC)
95
ATCC okt8 anti cd8
Okt8 Anti Cd8, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/okt8 anti cd8/product/ATCC
Average 95 stars, based on 1 article reviews
okt8 anti cd8 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
anti mouse cxcl9 mig antibody  (MedChemExpress)
93
MedChemExpress anti mouse cxcl9 mig antibody
Anti Mouse Cxcl9 Mig Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cxcl9 mig antibody/product/MedChemExpress
Average 93 stars, based on 1 article reviews
anti mouse cxcl9 mig antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
monoclonal anti-human antibody cd8 clone okt-8  (Bio X Cell)
90
Bio X Cell monoclonal anti-human antibody cd8 clone okt-8
T cell response to BNT162b2 mRNA vaccination in patients with cancer. (A) Representative flow cytometry plots showing IFNg expression of <t>CD8</t> + (upper row) and CD4 + (lower row) T cells in a healthy individual after stimulation with DMSO (negative control), spike pool 1 (S1), spike pool 2 (S2) and PMA and Ionomycin (positive control), respectively. Percentage of IFNg expressing CD8 + (B) and CD4 + (C) T cells in patients with cancer receiving checkpoint inhibition (Checkpoint, n=4), tyrosine kinase inhibitors (TKI, n=9), B cell depleting therapies (anti-CD20, n=5), antibody therapy (n=8), immunotherapy with concomitant chemotherapy (Cht-ICI, n=12), chemotherapy (chemo, n=24) and corticosteroids (cortisone, n=31) and healthy individuals (HD, n=9) after stimulation with S1 and S2, respectively. Each dot represents one donor and was calculated by background subtraction. Mann-Whitney U test was performed to calculate significance with *p<0.05, **p<0.01.
Monoclonal Anti Human Antibody Cd8 Clone Okt 8, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal anti-human antibody cd8 clone okt-8/product/Bio X Cell
Average 90 stars, based on 1 article reviews
monoclonal anti-human antibody cd8 clone okt-8 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
acd3:okt3  (IBA GmbH)
90
IBA GmbH acd3:okt3
T cell response to BNT162b2 mRNA vaccination in patients with cancer. (A) Representative flow cytometry plots showing IFNg expression of <t>CD8</t> + (upper row) and CD4 + (lower row) T cells in a healthy individual after stimulation with DMSO (negative control), spike pool 1 (S1), spike pool 2 (S2) and PMA and Ionomycin (positive control), respectively. Percentage of IFNg expressing CD8 + (B) and CD4 + (C) T cells in patients with cancer receiving checkpoint inhibition (Checkpoint, n=4), tyrosine kinase inhibitors (TKI, n=9), B cell depleting therapies (anti-CD20, n=5), antibody therapy (n=8), immunotherapy with concomitant chemotherapy (Cht-ICI, n=12), chemotherapy (chemo, n=24) and corticosteroids (cortisone, n=31) and healthy individuals (HD, n=9) after stimulation with S1 and S2, respectively. Each dot represents one donor and was calculated by background subtraction. Mann-Whitney U test was performed to calculate significance with *p<0.05, **p<0.01.
Acd3:Okt3, supplied by IBA GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/acd3:okt3/product/IBA GmbH
Average 90 stars, based on 1 article reviews
acd3:okt3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
t-cytotoxic/ suppressor lymphocytes (okt-8) (cd8)  (Becton Dickinson)
90
Becton Dickinson t-cytotoxic/ suppressor lymphocytes (okt-8) (cd8)
T cell response to BNT162b2 mRNA vaccination in patients with cancer. (A) Representative flow cytometry plots showing IFNg expression of <t>CD8</t> + (upper row) and CD4 + (lower row) T cells in a healthy individual after stimulation with DMSO (negative control), spike pool 1 (S1), spike pool 2 (S2) and PMA and Ionomycin (positive control), respectively. Percentage of IFNg expressing CD8 + (B) and CD4 + (C) T cells in patients with cancer receiving checkpoint inhibition (Checkpoint, n=4), tyrosine kinase inhibitors (TKI, n=9), B cell depleting therapies (anti-CD20, n=5), antibody therapy (n=8), immunotherapy with concomitant chemotherapy (Cht-ICI, n=12), chemotherapy (chemo, n=24) and corticosteroids (cortisone, n=31) and healthy individuals (HD, n=9) after stimulation with S1 and S2, respectively. Each dot represents one donor and was calculated by background subtraction. Mann-Whitney U test was performed to calculate significance with *p<0.05, **p<0.01.
T Cytotoxic/ Suppressor Lymphocytes (Okt 8) (Cd8), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/t-cytotoxic/ suppressor lymphocytes (okt-8) (cd8)/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
t-cytotoxic/ suppressor lymphocytes (okt-8) (cd8) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
okt8 (specific for cd8) antibody  (LGC Promochem)
90
LGC Promochem okt8 (specific for cd8) antibody
T cell response to BNT162b2 mRNA vaccination in patients with cancer. (A) Representative flow cytometry plots showing IFNg expression of <t>CD8</t> + (upper row) and CD4 + (lower row) T cells in a healthy individual after stimulation with DMSO (negative control), spike pool 1 (S1), spike pool 2 (S2) and PMA and Ionomycin (positive control), respectively. Percentage of IFNg expressing CD8 + (B) and CD4 + (C) T cells in patients with cancer receiving checkpoint inhibition (Checkpoint, n=4), tyrosine kinase inhibitors (TKI, n=9), B cell depleting therapies (anti-CD20, n=5), antibody therapy (n=8), immunotherapy with concomitant chemotherapy (Cht-ICI, n=12), chemotherapy (chemo, n=24) and corticosteroids (cortisone, n=31) and healthy individuals (HD, n=9) after stimulation with S1 and S2, respectively. Each dot represents one donor and was calculated by background subtraction. Mann-Whitney U test was performed to calculate significance with *p<0.05, **p<0.01.
Okt8 (Specific For Cd8) Antibody, supplied by LGC Promochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/okt8 (specific for cd8) antibody/product/LGC Promochem
Average 90 stars, based on 1 article reviews
okt8 (specific for cd8) antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
okt8  (Caprico Biotechnologies)
90
Caprico Biotechnologies okt8
Monoclonal antibodies used in flow cytometry.
Okt8, supplied by Caprico Biotechnologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/okt8/product/Caprico Biotechnologies
Average 90 stars, based on 1 article reviews
okt8 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
okt-8 antibody  (Agenus Inc)
90
Agenus Inc okt-8 antibody
Monoclonal antibodies used in flow cytometry.
Okt 8 Antibody, supplied by Agenus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/okt-8 antibody/product/Agenus Inc
Average 90 stars, based on 1 article reviews
okt-8 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-mouse immunoglobulin g (igg)-conjugated immunomagnetic beads loaded with okt8 monoclonal antibody  (Immunotec inc)
90
Immunotec inc anti-mouse immunoglobulin g (igg)-conjugated immunomagnetic beads loaded with okt8 monoclonal antibody
Monoclonal antibodies used in flow cytometry.
Anti Mouse Immunoglobulin G (Igg) Conjugated Immunomagnetic Beads Loaded With Okt8 Monoclonal Antibody, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-mouse immunoglobulin g (igg)-conjugated immunomagnetic beads loaded with okt8 monoclonal antibody/product/Immunotec inc
Average 90 stars, based on 1 article reviews
anti-mouse immunoglobulin g (igg)-conjugated immunomagnetic beads loaded with okt8 monoclonal antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mouse anti-human cd8 okt8  (Dakewe Biotech Co)
90
Dakewe Biotech Co mouse anti-human cd8 okt8
Monoclonal antibodies used in flow cytometry.
Mouse Anti Human Cd8 Okt8, supplied by Dakewe Biotech Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-human cd8 okt8/product/Dakewe Biotech Co
Average 90 stars, based on 1 article reviews
mouse anti-human cd8 okt8 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


T cell response to BNT162b2 mRNA vaccination in patients with cancer. (A) Representative flow cytometry plots showing IFNg expression of CD8 + (upper row) and CD4 + (lower row) T cells in a healthy individual after stimulation with DMSO (negative control), spike pool 1 (S1), spike pool 2 (S2) and PMA and Ionomycin (positive control), respectively. Percentage of IFNg expressing CD8 + (B) and CD4 + (C) T cells in patients with cancer receiving checkpoint inhibition (Checkpoint, n=4), tyrosine kinase inhibitors (TKI, n=9), B cell depleting therapies (anti-CD20, n=5), antibody therapy (n=8), immunotherapy with concomitant chemotherapy (Cht-ICI, n=12), chemotherapy (chemo, n=24) and corticosteroids (cortisone, n=31) and healthy individuals (HD, n=9) after stimulation with S1 and S2, respectively. Each dot represents one donor and was calculated by background subtraction. Mann-Whitney U test was performed to calculate significance with *p<0.05, **p<0.01.

Journal: Journal for Immunotherapy of Cancer

Article Title: Responses of patients with cancer to mRNA vaccines depend on the time interval between vaccination and last treatment

doi: 10.1136/jitc-2023-007387

Figure Lengend Snippet: T cell response to BNT162b2 mRNA vaccination in patients with cancer. (A) Representative flow cytometry plots showing IFNg expression of CD8 + (upper row) and CD4 + (lower row) T cells in a healthy individual after stimulation with DMSO (negative control), spike pool 1 (S1), spike pool 2 (S2) and PMA and Ionomycin (positive control), respectively. Percentage of IFNg expressing CD8 + (B) and CD4 + (C) T cells in patients with cancer receiving checkpoint inhibition (Checkpoint, n=4), tyrosine kinase inhibitors (TKI, n=9), B cell depleting therapies (anti-CD20, n=5), antibody therapy (n=8), immunotherapy with concomitant chemotherapy (Cht-ICI, n=12), chemotherapy (chemo, n=24) and corticosteroids (cortisone, n=31) and healthy individuals (HD, n=9) after stimulation with S1 and S2, respectively. Each dot represents one donor and was calculated by background subtraction. Mann-Whitney U test was performed to calculate significance with *p<0.05, **p<0.01.

Article Snippet: Single cell suspensions were stained using in house labeled monoclonal anti-human antibodies: CD8 (clone OKT-8, BioXCell), CD4 (clone RPA-T4, BioXCell), CD3 (clone UCHT1, BioXCell) and IFNg (clone: B27, BioXCell).

Techniques: Flow Cytometry, Expressing, Negative Control, Positive Control, Inhibition, MANN-WHITNEY

Third BNT162b2 boost vaccination in patients with ongoing B cell depleting therapies. Blood and serum samples were obtained one to 5 months post third vaccination with BNT162b2. (A) Anti-SARS-CoV-2 spike-specific IgG titers (U/mL) compared between patients receiving anti-CD20 therapy (n=9) and healthy donors (HD; n=9). Percentage of IFNg producing CD8 + (B) and CD4 + (C) T cells in after stimulation with spike pool 1 (S1) or spike pool 2 (S2) compared between patients receiving anti-CD20 therapy (n=19) and (HD; n=9). Mann-Whitney U test was performed to calculate significance with *p<0.05, **p<0.01, ***p<0.001 and ns not significant.

Journal: Journal for Immunotherapy of Cancer

Article Title: Responses of patients with cancer to mRNA vaccines depend on the time interval between vaccination and last treatment

doi: 10.1136/jitc-2023-007387

Figure Lengend Snippet: Third BNT162b2 boost vaccination in patients with ongoing B cell depleting therapies. Blood and serum samples were obtained one to 5 months post third vaccination with BNT162b2. (A) Anti-SARS-CoV-2 spike-specific IgG titers (U/mL) compared between patients receiving anti-CD20 therapy (n=9) and healthy donors (HD; n=9). Percentage of IFNg producing CD8 + (B) and CD4 + (C) T cells in after stimulation with spike pool 1 (S1) or spike pool 2 (S2) compared between patients receiving anti-CD20 therapy (n=19) and (HD; n=9). Mann-Whitney U test was performed to calculate significance with *p<0.05, **p<0.01, ***p<0.001 and ns not significant.

Article Snippet: Single cell suspensions were stained using in house labeled monoclonal anti-human antibodies: CD8 (clone OKT-8, BioXCell), CD4 (clone RPA-T4, BioXCell), CD3 (clone UCHT1, BioXCell) and IFNg (clone: B27, BioXCell).

Techniques: MANN-WHITNEY

Monoclonal antibodies used in flow cytometry.

Journal: International Journal of Molecular Sciences

Article Title: Human Amniotic MSC Response in LPS-Stimulated Ascites from Patients with Cirrhosis: FOXO1 Gene and Th17 Activation in Enhanced Antibacterial Activation

doi: 10.3390/ijms25052801

Figure Lengend Snippet: Monoclonal antibodies used in flow cytometry.

Article Snippet: CD8 , APC-Cy7 , OKT8 , 1:20 , Caprico Biotechnologies (Norcross, GA, USA).

Techniques: Cytometry, Conjugation Assay